Financials in USD. Standardized financial statements.
A compact view of how Silk Road Medical, Inc turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|
| Revenue? | $177.13M | $138.64M | $101.47M | $75.23M | $63.35M | $34.56M | $14.26M |
| Revenue Growth? | +27.8% | +36.6% | +34.9% | +18.7% | +83.3% | +142.4% | 0.0% |
| Cost of Revenue? | $50.05M | $37.88M | $25.45M | $21.29M | $15.93M | $10.87M | $5.13M |
| Gross Profit? | $127.09M | $100.76M | $76.03M | $53.94M | $47.43M | $23.68M | $9.13M |
| Gross Margin? | +71.7% | +72.7% | +74.9% | +71.7% | +74.9% | +68.5% | +64.0% |
| Operating Expenses? | $186.36M | $152.77M | $123.50M | $96.80M | $75.49M | $45.08M | $27.50M |
| Operating Income? | -$59.27M | -$52.00M | -$47.47M | -$42.86M | -$28.07M | -$21.39M | -$18.37M |
| EBITDA? | -$45.08M | -$46.74M | -$45.55M | -$41.47M | -$46.17M | -$32.75M | -$18.25M |
| Income Before Tax | -$55.74M | -$55.01M | -$49.81M | -$47.37M | -$52.41M | -$37.63M | -$19.36M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$55.74M | -$58.02M | -$50.39M | -$50.38M | -$56.07M | -$37.63M | -$19.36M |
| EPS? | $-1.44 | $-1.62 | $-1.45 | $-1.53 | $-2.44 | $-1.31 | $-0.80 |
| Diluted EPS? | $-1.44 | $-1.62 | $-1.45 | $-1.53 | $-2.44 | $-1.31 | $-0.80 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality